Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human immunization in developing countries: practical and theoretical problems and prospects

S C Arya1

  • 1Centre for Logistical Research & Innovation, New Delhi, India.

Vaccine
|November 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acquisition of spongiform encephalo-pathies in India through sheep-brain rabies vaccination.

The National medical journal of India·2018
Same author

Apropos 'A simple and inexpensive point-of-care test for hepatitis B surface antigen detection: serological and molecular evaluation' - a suggestion.

Journal of viral hepatitis·2014
Same author

Letter: chronic Salmonella typhi carrier status and gall-bladder cancer.

Alimentary pharmacology & therapeutics·2014
Same author

Comment on "Platelet transfusion: basic aspects".

Swiss medical weekly·2014
Same author

Immunity status against poliomyelitis in childbearing women in a province of northern Italy.

Annali di igiene : medicina preventiva e di comunita·2014
Same author

Apropos 'a review of dengue as an emerging disease in Pakistan'.

Public health·2013
Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026
Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026
See all related articles

Developing countries face high communicable disease deaths due to poor vaccine practices and infrastructure, unlike industrialized nations. Solutions require stable vaccines, international aid, and quality control for effective immunization programs.

Area of Science:

  • Global Health
  • Immunology
  • Public Health Policy

Background:

  • Communicable diseases like measles, pertussis, and tetanus caused millions of deaths in developing nations in the early 1990s, contrasting sharply with industrialized countries.
  • Developing countries disproportionately bear the burden of global deaths from communicable diseases, with respiratory infections being a leading cause of morbidity.
  • Despite local vaccine production capabilities for bacterial, viral, and passive immunization, developing nations lack manufacturing for plasma-derived prophylactics and biological response modifiers, relying heavily on imports.

Purpose of the Study:

  • To highlight the disparities in communicable disease mortality between developing and industrialized countries.
  • To identify key factors contributing to the suboptimal performance of vaccines in developing regions.
  • To propose strategies for improving vaccine efficacy and expanding immunization coverage.
Keywords:
Causes Of DeathCommunicable DiseasesCritiqueDelivery Of Health CareDemographic FactorsDeveloping CountriesDiseasesHealthHealth ServicesHealth Services EvaluationImmunizationInfectionsMorbidityMortalityOrganization And AdministrationPopulationPopulation DynamicsPrimary Health CareProgram EvaluationProgramsQuality Of Health CareVaccines

Related Experiment Videos

Main Methods:

  • Analysis of global mortality and morbidity data for communicable diseases, focusing on disparities between developing and industrialized countries.
  • Examination of vaccine production, import reliance, and administration practices in developing nations.
  • Review of challenges including population growth, poverty, education, cold-chain logistics, and funding constraints for immunization programs.

Main Results:

  • Developing countries experienced significantly higher mortality from vaccine-preventable diseases and communicable diseases overall.
  • Suboptimal vaccine performance was attributed to faulty administration, cold-chain failures, and logistical challenges in reaching remote populations.
  • Financial strains from AIDS/HIV prevention and management have further hampered routine childhood and pregnancy vaccination efforts.

Conclusions:

  • Improving vaccine administration, ensuring cold-chain integrity, and enhancing transport logistics are critical for effective immunization.
  • Research into environmentally stable vaccines and monoclonal antibodies, coupled with international financial and technical support, is essential.
  • Strengthening national quality control of both imported and indigenous vaccines, alongside private clinician involvement, can bolster communicable disease control efforts, but local factors must be addressed.